Brazil Insulin Delivery Devices Market Size & Outlook
Brazil insulin delivery devices market, 2018-2030 (US$M)
Related Markets
Brazil insulin delivery devices market highlights
- The Brazil insulin delivery devices market generated a revenue of USD 294.8 million in 2023 and is expected to reach USD 479.5 million by 2030.
- The Brazil market is expected to grow at a CAGR of 7.2% from 2024 to 2030.
- In terms of segment, insulin pens was the largest revenue generating product in 2023.
- Insulin Pumps is the most lucrative product segment registering the fastest growth during the forecast period.
Insulin delivery devices market data book summary
| Market revenue in 2023 | USD 294.8 million |
| Market revenue in 2030 | USD 479.5 million |
| Growth rate | 7.2% (CAGR from 2023 to 2030) |
| Largest segment | Insulin pens |
| Fastest growing segment | Insulin Pumps |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Insulin Pens, Insulin Pumps, Insulin Pen Needles, Insulin Syringes |
| Key market players worldwide | Novo Nordisk A/S ADR, Sanofi SA, Eli Lilly and Co, Ypsomed Holding AG, Medtronic PLC, Abbott Laboratories, Roche, Biocon, Wockhardt |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.8% of the global insulin delivery devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil insulin delivery devices market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 479.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Insulin Delivery Devices Market Scope
Insulin Delivery Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil insulin delivery devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to insulin delivery devices market will help companies and investors design strategic landscapes.
Insulin pens was the largest segment with a revenue share of 44.06% in 2023. Horizon Databook has segmented the Brazil insulin delivery devices market based on insulin pens, insulin pumps, insulin pen needles, insulin syringes covering the revenue growth of each sub-segment from 2018 to 2030.
The IDF Diabetes Atlas 2021 revealed that in Brazil, approximately 15.7 million adults, equivalent to 10.5% of the adult population, are currently living with diabetes. This high prevalence of diabetes resulted in Brazil having the third-highest diabetes-related health expenditure in the world, at USD 42.9 billion.
Furthermore, about 18 million adults, or 11.9%, have Impaired Glucose Tolerance (IGT), placing them at a high risk of developing type 2 diabetes. In Brazil, 32% of people living with diabetes remain undiagnosed.
In addition, only 25% of individuals with diabetes were able to achieve the therapeutic goal of glycated hemoglobin (HbA1c)<7% before the pandemic, as recommended by the Brazilian Diabetes Society (SBD).
Reasons to subscribe to Brazil insulin delivery devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil insulin delivery devices market databook
-
Our clientele includes a mix of insulin delivery devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil insulin delivery devices market , including forecasts for subscribers. This country databook contains high-level insights into Brazil insulin delivery devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil insulin delivery devices market size, by end use, 2018-2030 (US$M)
Brazil Insulin Delivery Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
